Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus
NCT00565162
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
Insulin Glargine
Sponsor
Sanofi